BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+10.69%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.63B
AUM Growth
+$354M
(+8.3%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
6.93%
Holding
1,360
New
97
Increased
499
Reduced
329
Closed
107
Top Buys
| 1 |
Phinia Inc
PHIN
|
$19.7M |
| 2 |
TEGNA Inc
TGNA
|
$18.1M |
| 3 |
Kohl's
KSS
|
$15.6M |
| 4 |
Central Garden & Pet Class A
CENTA
|
$13.7M |
| 5 |
Adient
ADNT
|
$12M |
Top Sells
| 1 |
Merchants Bancorp
MBIN
|
$10.7M |
| 2 |
Abercrombie & Fitch
ANF
|
$10.1M |
| 3 |
Applovin
APP
|
$7.89M |
| 4 |
CleanSpark
CLSK
|
$7.03M |
| 5 |
Sinclair Inc
SBGI
|
$6.69M |
Sector Composition
| 1 | Financials | 27.27% |
| 2 | Consumer Discretionary | 14.01% |
| 3 | Industrials | 12.46% |
| 4 | Technology | 10.12% |
| 5 | Healthcare | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Verrica Pharmaceuticals
VRCA
$48.2M
| $82.9K | ﹤0.01% |
5,720
-2,500
| -30% | -$36.3K |
|
1177
SIFCO Industries
SIF
$43.8M
| $77.5K | ﹤0.01% |
16,674
| – | – |
|
1178
FibroBiologics
FBLG
$24.1M
| $77.3K | ﹤0.01% |
+25,000
| New | +$77.3K |
|
|
ELEV
1179
DELISTED
Elevation Oncology
ELEV
| $76.8K | ﹤0.01% |
128,000
| – | – |
|
1180
MEI Pharma
MEIP
$139M
| $76.6K | ﹤0.01% |
26,869
| – | – |
|
1181
Arena Group
AREN
$300M
| $76.3K | ﹤0.01% |
94,800
| – | – |
|
|
LUMO
1182
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $76K | ﹤0.01% |
19,643
-8,000
| -29% | -$31K |
|
1183
INNOVATE Corp
VATE
$75.2M
| $75.9K | ﹤0.01% |
+20,500
| New | +$75.9K |
|
1184
Mega Matrix
MPU
$103M
| $75.2K | ﹤0.01% |
74,500
| – | – |
|
1185
TrueCar
TRUE
$191M
| $74.5K | ﹤0.01% |
21,600
| – | – |
|
1186
Laird Superfood
LSF
$61.3M
| $74.4K | ﹤0.01% |
15,000
| – | – |
|
1187
Optical Cable Corp
OCC
$52.2M
| $74K | ﹤0.01% |
27,600
| – | – |
|
1188
CPI Aerostructures
CVU
$31.5M
| $72.9K | ﹤0.01% |
21,200
| – | – |
|
1189
Immuneering
IMRX
$229M
| $72.1K | ﹤0.01% |
28,949
-25,000
| -46% | -$62.3K |
|
1190
Kartoon Studios
TOON
$38.5M
| $69.5K | ﹤0.01% |
80,400
| – | – |
|
|
GRTS
1191
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $69.2K | ﹤0.01% |
119,400
-20,000
| -14% | -$11.6K |
|
1192
TriSalus Life Sciences
TLSI
$249M
| $69.2K | ﹤0.01% |
+15,000
| New | +$69.2K |
|
1193
Quince Therapeutics
QNCX
$86.5M
| $68.7K | ﹤0.01% |
88,495
-50,000
| -36% | -$38.8K |
|
1194
OptimumBank Holdings
OPHC
$49.7M
| $68.6K | ﹤0.01% |
+15,000
| New | +$68.6K |
|
1195
Outset Medical
OM
$249M
| $67.7K | ﹤0.01% |
+6,667
| New | +$67.7K |
|
1196
Exagen
XGN
$213M
| $67.4K | ﹤0.01% |
21,800
| – | – |
|
1197
Vicarious Surgical
RBOT
$33.9M
| $67K | ﹤0.01% |
+11,800
| New | +$67K |
|
1198
NanoViricides
NNVC
$23.9M
| $66.1K | ﹤0.01% |
44,039
-15,000
| -25% | -$22.5K |
|
1199
Elicio Therapeutics
ELTX
$188M
| $62.9K | ﹤0.01% |
12,500
| – | – |
|
1200
Lantronix
LTRX
$185M
| $62.6K | ﹤0.01% |
15,200
| – | – |
|